The Journal of heart valve disease · 2008
Aortic valve replacement: ten-year follow up of the Ross procedure.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Favaloro Roberto R, Roura Pablo, Gomez Carmen, Salvatori Carolina
Аннотация
BACKGROUND AND AIM OF THE STUDY: The study aim was to assess the long-term results of the Ross procedure in the treatment of aortic valve disease.
METHODS: Between July 1995 and May 2006, a total of 165 patients (131 males, 34 females; mean age 39 +/- 13 years) underwent the Ross procedure using the freestanding root technique. Both, clinical and echocardiographic follow ups were conducted, with valve-associated events (death, endocarditis, thromboembolism, reoperation, valvular dysfunction) being analyzed using Kaplan-Meier curves. Log-rank tests, chi-square tests and the Cox model were used for variable analysis.
RESULTS: The mean preoperative left ventricular ejection fraction was 55 +/- 12%. Surgery was indicated for aortic stenosis (54%) or aortic insufficiency (46%). The aortic valve was bicuspid in 125 patients, while in four patients surgery was indicated in the setting of active infective endocarditis, and in six for prosthetic dysfunction. The in-hospital mortality was 2.5% (n = 4). Survival at one and 10 years was 97% (95% CI, 93-99) and 94.8% (95% CI, 89-98), respectively. Freedom from endocarditis at 10 years was 95% (95% CI, 84-98), and from valve-related events was 95% (95% CI, 90-98) and 88% (95% CI, 75-94) at one and 10 years, respectively. Four patients required reoperation (one case of recurrent mitral regurgitation after previous mitral valve repair; three cases of autograft dysfunction and disease of other valves). Based on this experience, and during the follow up period, the presence of aortic regurgitation as a baseline aortic lesion was not associated with any need for reoperation.
CONCLUSION: As a surgical technique, the Ross procedure has a low event rate at 10 years after surgery, and may be considered a valid alternative for the treatment of aortic valve disease.
METHODS: Between July 1995 and May 2006, a total of 165 patients (131 males, 34 females; mean age 39 +/- 13 years) underwent the Ross procedure using the freestanding root technique. Both, clinical and echocardiographic follow ups were conducted, with valve-associated events (death, endocarditis, thromboembolism, reoperation, valvular dysfunction) being analyzed using Kaplan-Meier curves. Log-rank tests, chi-square tests and the Cox model were used for variable analysis.
RESULTS: The mean preoperative left ventricular ejection fraction was 55 +/- 12%. Surgery was indicated for aortic stenosis (54%) or aortic insufficiency (46%). The aortic valve was bicuspid in 125 patients, while in four patients surgery was indicated in the setting of active infective endocarditis, and in six for prosthetic dysfunction. The in-hospital mortality was 2.5% (n = 4). Survival at one and 10 years was 97% (95% CI, 93-99) and 94.8% (95% CI, 89-98), respectively. Freedom from endocarditis at 10 years was 95% (95% CI, 84-98), and from valve-related events was 95% (95% CI, 90-98) and 88% (95% CI, 75-94) at one and 10 years, respectively. Four patients required reoperation (one case of recurrent mitral regurgitation after previous mitral valve repair; three cases of autograft dysfunction and disease of other valves). Based on this experience, and during the follow up period, the presence of aortic regurgitation as a baseline aortic lesion was not associated with any need for reoperation.
CONCLUSION: As a surgical technique, the Ross procedure has a low event rate at 10 years after surgery, and may be considered a valid alternative for the treatment of aortic valve disease.